SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GelTex Pharmaceuticals (GELX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert L. Ray who wrote (63)7/30/1998 1:41:00 AM
From: rkrw  Read Replies (1) of 127
 
Robert,
What you have to remember is that 20% royalties is often roughly equivalent to a 50/50 deal since costs are borne equally between partners. I don't believe that GELX has the desire to create the sales force necessary to support a 50/50 deal with a big partner in such a tightly contested and expensive (marketing) market. I'm afraid you are setting yourself up for a major disappointment. Nice to see GELX strong, although frankly I am kind of hoping to pick up more shares on the very cheap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News